发明授权
- 专利标题： Compounds that are ERK inhibitors
- 专利标题（中）： ERK抑制剂的化合物
-
申请号： US11705709申请日： 2007-02-13
-
公开(公告)号： US07807672B2公开(公告)日： 2010-10-05
- 发明人: Yongqi Deng , Gerald W. Shipps, Jr. , Alan Cooper , Yang Nan , Tong Wang , M. Arshad Siddiqui , Hugh Zhu , Robert Sun , Joseph M. Kelly , Ronald Doll , Jagdish Desai , James J-S Wang , Youhao Dong , Vincent Madison , Li Xiao , Alan Hruza , Neng-Yang Shih
- 申请人： Yongqi Deng , Gerald W. Shipps, Jr. , Alan Cooper , Yang Nan , Tong Wang , M. Arshad Siddiqui , Hugh Zhu , Robert Sun , Joseph M. Kelly , Ronald Doll , Jagdish Desai , James J-S Wang , Youhao Dong , Vincent Madison , Li Xiao , Alan Hruza , Neng-Yang Shih
- 申请人地址： US NJ Kenilworth
- 专利权人： Schering Corporation
- 当前专利权人： Schering Corporation
- 当前专利权人地址： US NJ Kenilworth
- 代理商 Henry C. Jeanette
- 主分类号： A61K31/506
- IPC分类号： A61K31/506 ; A61K31/5377 ; A61K31/4025 ; A61K31/496 ; C07D401/06 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D405/12 ; C07D413/12 ; C07D417/06 ; C07D417/12
摘要：
Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substituents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.
公开/授权文献
- US20070232610A1 Novel compounds that are ERK inhibitors 公开/授权日：2007-10-04
信息查询
IPC分类:
